Global Vaccine Market Size, Status and Forecast 2023

Report ID: 1234892 | Published Date: Oct 2024 | No. of Page: 125 | Base Year: 2023 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Vaccine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Varicella Vaccine
        1.2.3 Influenza Vaccine
        1.2.4 Polio Vaccine
        1.2.5 Hepatitis A Vaccine
        1.2.6 Rabies Vaccine
        1.2.7 BCG Vaccine
        1.2.8 Hepatitis B
        1.2.9 Pertussis, Diphtheria, Tetanus
        1.2.10 Pneumococcal
        1.2.11 Others
    1.3 Market by Application
        1.3.1 Global Vaccine Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 For Adult
        1.3.3 For Child
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Vaccine Market Perspective (2016-2027)
    2.2 Vaccine Growth Trends by Regions
        2.2.1 Vaccine Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Vaccine Historic Market Share by Regions (2016-2021)
        2.2.3 Vaccine Forecasted Market Size by Regions (2022-2027)
    2.3 Vaccine Industry Dynamic
        2.3.1 Vaccine Market Trends
        2.3.2 Vaccine Market Drivers
        2.3.3 Vaccine Market Challenges
        2.3.4 Vaccine Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Vaccine Players by Revenue
        3.1.1 Global Top Vaccine Players by Revenue (2016-2021)
        3.1.2 Global Vaccine Revenue Market Share by Players (2016-2021)
    3.2 Global Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Vaccine Revenue
    3.4 Global Vaccine Market Concentration Ratio
        3.4.1 Global Vaccine Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Vaccine Revenue in 2020
    3.5 Vaccine Key Players Head office and Area Served
    3.6 Key Players Vaccine Product Solution and Service
    3.7 Date of Enter into Vaccine Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Vaccine Breakdown Data by Type
    4.1 Global Vaccine Historic Market Size by Type (2016-2021)
    4.2 Global Vaccine Forecasted Market Size by Type (2022-2027)

5 Vaccine Breakdown Data by Application
    5.1 Global Vaccine Historic Market Size by Application (2016-2021)
    5.2 Global Vaccine Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Vaccine Market Size (2016-2027)
    6.2 North America Vaccine Market Size by Type
        6.2.1 North America Vaccine Market Size by Type (2016-2021)
        6.2.2 North America Vaccine Market Size by Type (2022-2027)
        6.2.3 North America Vaccine Market Size by Type (2016-2027)
    6.3 North America Vaccine Market Size by Application
        6.3.1 North America Vaccine Market Size by Application (2016-2021)
        6.3.2 North America Vaccine Market Size by Application (2022-2027)
        6.3.3 North America Vaccine Market Size by Application (2016-2027)
    6.4 North America Vaccine Market Size by Country
        6.4.1 North America Vaccine Market Size by Country (2016-2021)
        6.4.2 North America Vaccine Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Vaccine Market Size (2016-2027)
    7.2 Europe Vaccine Market Size by Type
        7.2.1 Europe Vaccine Market Size by Type (2016-2021)
        7.2.2 Europe Vaccine Market Size by Type (2022-2027)
        7.2.3 Europe Vaccine Market Size by Type (2016-2027)
    7.3 Europe Vaccine Market Size by Application
        7.3.1 Europe Vaccine Market Size by Application (2016-2021)
        7.3.2 Europe Vaccine Market Size by Application (2022-2027)
        7.3.3 Europe Vaccine Market Size by Application (2016-2027)
    7.4 Europe Vaccine Market Size by Country
        7.4.1 Europe Vaccine Market Size by Country (2016-2021)
        7.4.2 Europe Vaccine Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Vaccine Market Size (2016-2027)
    8.2 Asia-Pacific Vaccine Market Size by Type
        8.2.1 Asia-Pacific Vaccine Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Vaccine Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Vaccine Market Size by Type (2016-2027)
    8.3 Asia-Pacific Vaccine Market Size by Application
        8.3.1 Asia-Pacific Vaccine Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Vaccine Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Vaccine Market Size by Application (2016-2027)
    8.4 Asia-Pacific Vaccine Market Size by Region
        8.4.1 Asia-Pacific Vaccine Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Vaccine Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Vaccine Market Size (2016-2027)
    9.2 Latin America Vaccine Market Size by Type
        9.2.1 Latin America Vaccine Market Size by Type (2016-2021)
        9.2.2 Latin America Vaccine Market Size by Type (2022-2027)
        9.2.3 Latin America Vaccine Market Size by Type (2016-2027)
    9.3 Latin America Vaccine Market Size by Application
        9.3.1 Latin America Vaccine Market Size by Application (2016-2021)
        9.3.2 Latin America Vaccine Market Size by Application (2022-2027)
        9.3.3 Latin America Vaccine Market Size by Application (2016-2027)
    9.4 Latin America Vaccine Market Size by Country
        9.4.1 Latin America Vaccine Market Size by Country (2016-2021)
        9.4.2 Latin America Vaccine Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Vaccine Market Size (2016-2027)
    10.2 Middle East & Africa Vaccine Market Size by Type
        10.2.1 Middle East & Africa Vaccine Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Vaccine Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Vaccine Market Size by Type (2016-2027)
    10.3 Middle East & Africa Vaccine Market Size by Application
        10.3.1 Middle East & Africa Vaccine Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Vaccine Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Vaccine Market Size by Application (2016-2027)
    10.4 Middle East & Africa Vaccine Market Size by Country
        10.4.1 Middle East & Africa Vaccine Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Vaccine Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 AstraZeneca
        11.1.1 AstraZeneca Company Details
        11.1.2 AstraZeneca Business Overview
        11.1.3 AstraZeneca Vaccine Introduction
        11.1.4 AstraZeneca Revenue in Vaccine Business (2016-2021)
        11.1.5 AstraZeneca Recent Development
    11.2 BioNTech
        11.2.1 BioNTech Company Details
        11.2.2 BioNTech Business Overview
        11.2.3 BioNTech Vaccine Introduction
        11.2.4 BioNTech Revenue in Vaccine Business (2016-2021)
        11.2.5 BioNTech Recent Development
    11.3 Boehringer-Ingelheim
        11.3.1 Boehringer-Ingelheim Company Details
        11.3.2 Boehringer-Ingelheim Business Overview
        11.3.3 Boehringer-Ingelheim Vaccine Introduction
        11.3.4 Boehringer-Ingelheim Revenue in Vaccine Business (2016-2021)
        11.3.5 Boehringer-Ingelheim Recent Development
    11.4 CCBIO
        11.4.1 CCBIO Company Details
        11.4.2 CCBIO Business Overview
        11.4.3 CCBIO Vaccine Introduction
        11.4.4 CCBIO Revenue in Vaccine Business (2016-2021)
        11.4.5 CCBIO Recent Development
    11.5 CSL
        11.5.1 CSL Company Details
        11.5.2 CSL Business Overview
        11.5.3 CSL Vaccine Introduction
        11.5.4 CSL Revenue in Vaccine Business (2016-2021)
        11.5.5 CSL Recent Development
    11.6 CureVac
        11.6.1 CureVac Company Details
        11.6.2 CureVac Business Overview
        11.6.3 CureVac Vaccine Introduction
        11.6.4 CureVac Revenue in Vaccine Business (2016-2021)
        11.6.5 CureVac Recent Development
    11.7 Elanco
        11.7.1 Elanco Company Details
        11.7.2 Elanco Business Overview
        11.7.3 Elanco Vaccine Introduction
        11.7.4 Elanco Revenue in Vaccine Business (2016-2021)
        11.7.5 Elanco Recent Development
    11.8 GSK
        11.8.1 GSK Company Details
        11.8.2 GSK Business Overview
        11.8.3 GSK Vaccine Introduction
        11.8.4 GSK Revenue in Vaccine Business (2016-2021)
        11.8.5 GSK Recent Development
    11.9 Hulan Bio
        11.9.1 Hulan Bio Company Details
        11.9.2 Hulan Bio Business Overview
        11.9.3 Hulan Bio Vaccine Introduction
        11.9.4 Hulan Bio Revenue in Vaccine Business (2016-2021)
        11.9.5 Hulan Bio Recent Development
    11.10 Indian Immunologicals
        11.10.1 Indian Immunologicals Company Details
        11.10.2 Indian Immunologicals Business Overview
        11.10.3 Indian Immunologicals Vaccine Introduction
        11.10.4 Indian Immunologicals Revenue in Vaccine Business (2016-2021)
        11.10.5 Indian Immunologicals Recent Development
    11.11 Merck
        11.11.1 Merck Company Details
        11.11.2 Merck Business Overview
        11.11.3 Merck Vaccine Introduction
        11.11.4 Merck Revenue in Vaccine Business (2016-2021)
        11.11.5 Merck Recent Development
    11.12 Minhai Biotechnology
        11.12.1 Minhai Biotechnology Company Details
        11.12.2 Minhai Biotechnology Business Overview
        11.12.3 Minhai Biotechnology Vaccine Introduction
        11.12.4 Minhai Biotechnology Revenue in Vaccine Business (2016-2021)
        11.12.5 Minhai Biotechnology Recent Development
    11.13 Mitsubishi Tanabe Pharma
        11.13.1 Mitsubishi Tanabe Pharma Company Details
        11.13.2 Mitsubishi Tanabe Pharma Business Overview
        11.13.3 Mitsubishi Tanabe Pharma Vaccine Introduction
        11.13.4 Mitsubishi Tanabe Pharma Revenue in Vaccine Business (2016-2021)
        11.13.5 Mitsubishi Tanabe Pharma Recent Development
    11.14 Moderna Therapeutics
        11.14.1 Moderna Therapeutics Company Details
        11.14.2 Moderna Therapeutics Business Overview
        11.14.3 Moderna Therapeutics Vaccine Introduction
        11.14.4 Moderna Therapeutics Revenue in Vaccine Business (2016-2021)
        11.14.5 Moderna Therapeutics Recent Development
    11.15 Mylan
        11.15.1 Mylan Company Details
        11.15.2 Mylan Business Overview
        11.15.3 Mylan Vaccine Introduction
        11.15.4 Mylan Revenue in Vaccine Business (2016-2021)
        11.15.5 Mylan Recent Development
    11.16 Plumbline Life Sciences
        11.16.1 Plumbline Life Sciences Company Details
        11.16.2 Plumbline Life Sciences Business Overview
        11.16.3 Plumbline Life Sciences Vaccine Introduction
        11.16.4 Plumbline Life Sciences Revenue in Vaccine Business (2016-2021)
        11.16.5 Plumbline Life Sciences Recent Development
    11.17 Sanofi
        11.17.1 Sanofi Company Details
        11.17.2 Sanofi Business Overview
        11.17.3 Sanofi Vaccine Introduction
        11.17.4 Sanofi Revenue in Vaccine Business (2016-2021)
        11.17.5 Sanofi Recent Development
    11.18 Translate Bio
        11.18.1 Translate Bio Company Details
        11.18.2 Translate Bio Business Overview
        11.18.3 Translate Bio Vaccine Introduction
        11.18.4 Translate Bio Revenue in Vaccine Business (2016-2021)
        11.18.5 Translate Bio Recent Development
    11.19 Walvax Biotechnology
        11.19.1 Walvax Biotechnology Company Details
        11.19.2 Walvax Biotechnology Business Overview
        11.19.3 Walvax Biotechnology Vaccine Introduction
        11.19.4 Walvax Biotechnology Revenue in Vaccine Business (2016-2021)
        11.19.5 Walvax Biotechnology Recent Development
    11.20 Wuhan Institute of Biological Products
        11.20.1 Wuhan Institute of Biological Products Company Details
        11.20.2 Wuhan Institute of Biological Products Business Overview
        11.20.3 Wuhan Institute of Biological Products Vaccine Introduction
        11.20.4 Wuhan Institute of Biological Products Revenue in Vaccine Business (2016-2021)
        11.20.5 Wuhan Institute of Biological Products Recent Development
    11.21 Zoties
        11.21.1 Zoties Company Details
        11.21.2 Zoties Business Overview
        11.21.3 Zoties Vaccine Introduction
        11.21.4 Zoties Revenue in Vaccine Business (2016-2021)
        11.21.5 Zoties Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Vaccine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Varicella Vaccine
    Table 3. Key Players of Influenza Vaccine
    Table 4. Key Players of Polio Vaccine
    Table 5. Key Players of Hepatitis A Vaccine
    Table 6. Key Players of Rabies Vaccine
    Table 7. Key Players of BCG Vaccine
    Table 8. Key Players of Hepatitis B
    Table 9. Key Players of Pertussis, Diphtheria, Tetanus
    Table 10. Key Players of Pneumococcal
    Table 11. Key Players of Others
    Table 12. Global Vaccine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 13. Global Vaccine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 14. Global Vaccine Market Size by Regions (2016-2021) & (US$ Million)
    Table 15. Global Vaccine Market Share by Regions (2016-2021)
    Table 16. Global Vaccine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 17. Global Vaccine Market Share by Regions (2022-2027)
    Table 18. Vaccine Market Trends
    Table 19. Vaccine Market Drivers
    Table 20. Vaccine Market Challenges
    Table 21. Vaccine Market Restraints
    Table 22. Global Vaccine Revenue by Players (2016-2021) & (US$ Million)
    Table 23. Global Vaccine Market Share by Players (2016-2021)
    Table 24. Global Top Vaccine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccine as of 2020)
    Table 25. Ranking of Global Top Vaccine Companies by Revenue (US$ Million) in 2020
    Table 26. Global 5 Largest Players Market Share by Vaccine Revenue (CR5 and HHI) & (2016-2021)
    Table 27. Key Players Headquarters and Area Served
    Table 28. Key Players Vaccine Product Solution and Service
    Table 29. Date of Enter into Vaccine Market
    Table 30. Mergers & Acquisitions, Expansion Plans
    Table 31. Global Vaccine Market Size by Type (2016-2021) (US$ Million)
    Table 32. Global Vaccine Revenue Market Share by Type (2016-2021)
    Table 33. Global Vaccine Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 34. Global Vaccine Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 35. Global Vaccine Market Size Share by Application (2016-2021) & (US$ Million)
    Table 36. Global Vaccine Revenue Market Share by Application (2016-2021)
    Table 37. Global Vaccine Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 38. Global Vaccine Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 39. North America Vaccine Market Size by Type (2016-2021) (US$ Million)
    Table 40. North America Vaccine Market Size by Type (2022-2027) & (US$ Million)
    Table 41. North America Vaccine Market Size by Application (2016-2021) (US$ Million)
    Table 42. North America Vaccine Market Size by Application (2022-2027) & (US$ Million)
    Table 43. North America Vaccine Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. North America Vaccine Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Europe Vaccine Market Size by Type (2016-2021) (US$ Million)
    Table 46. Europe Vaccine Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Europe Vaccine Market Size by Application (2016-2021) (US$ Million)
    Table 48. Europe Vaccine Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Europe Vaccine Market Size by Country (2016-2021) & (US$ Million) 
    Table 50. Europe Vaccine Market Size by Country (2022-2027) & (US$ Million) 
    Table 51. Asia-Pacific Vaccine Market Size by Type (2016-2021) (US$ Million)
    Table 52. Asia-Pacific Vaccine Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Asia-Pacific Vaccine Market Size by Application (2016-2021) (US$ Million)
    Table 54. Asia-Pacific Vaccine Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Asia-Pacific Vaccine Market Size by Region (2016-2021) & (US$ Million) 
    Table 56. Asia-Pacific Vaccine Market Size by Region (2022-2027) & (US$ Million) 
    Table 57. Latin America Vaccine Market Size by Type (2016-2021) (US$ Million)
    Table 58. Latin America Vaccine Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Latin America Vaccine Market Size by Application (2016-2021) (US$ Million)
    Table 60. Latin America Vaccine Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Latin America Vaccine Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Latin America Vaccine Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. Middle East & Africa Vaccine Market Size by Type (2016-2021) (US$ Million)
    Table 64. Middle East & Africa Vaccine Market Size by Type (2022-2027) & (US$ Million)
    Table 65. Middle East & Africa Vaccine Market Size by Application (2016-2021) (US$ Million)
    Table 66. Middle East & Africa Vaccine Market Size by Application (2022-2027) & (US$ Million)
    Table 67. Middle East & Africa Vaccine Market Size by Country (2016-2021) & (US$ Million) 
    Table 68. Middle East & Africa Vaccine Market Size by Country (2022-2027) & (US$ Million) 
    Table 69. AstraZeneca Company Details
    Table 70. AstraZeneca Business Overview
    Table 71. AstraZeneca Vaccine Product
    Table 72. AstraZeneca Revenue in Vaccine Business (2016-2021) & (US$ Million)
    Table 73. AstraZeneca Recent Development
    Table 74. BioNTech Company Details
    Table 75. BioNTech Business Overview
    Table 76. BioNTech Vaccine Product
    Table 77. BioNTech Revenue in Vaccine Business (2016-2021) & (US$ Million)
    Table 78. BioNTech Recent Development
    Table 79. Boehringer-Ingelheim Company Details
    Table 80. Boehringer-Ingelheim Business Overview
    Table 81. Boehringer-Ingelheim Vaccine Product
    Table 82. Boehringer-Ingelheim Revenue in Vaccine Business (2016-2021) & (US$ Million)
    Table 83. Boehringer-Ingelheim Recent Development
    Table 84. CCBIO Company Details
    Table 85. CCBIO Business Overview
    Table 86. CCBIO Vaccine Product
    Table 87. CCBIO Revenue in Vaccine Business (2016-2021) & (US$ Million)
    Table 88. CCBIO Recent Development
    Table 89. CSL Company Details
    Table 90. CSL Business Overview
    Table 91. CSL Vaccine Product
    Table 92. CSL Revenue in Vaccine Business (2016-2021) & (US$ Million)
    Table 93. CSL Recent Development
    Table 94. CureVac Company Details
    Table 95. CureVac Business Overview
    Table 96. CureVac Vaccine Product
    Table 97. CureVac Revenue in Vaccine Business (2016-2021) & (US$ Million)
    Table 98. CureVac Recent Development
    Table 99. Elanco Company Details
    Table 100. Elanco Business Overview
    Table 101. Elanco Vaccine Product
    Table 102. Elanco Revenue in Vaccine Business (2016-2021) & (US$ Million)
    Table 103. Elanco Recent Development
    Table 104. GSK Company Details
    Table 105. GSK Business Overview
    Table 106. GSK Revenue in Vaccine Business (2016-2021) & (US$ Million)
    Table 107. GSK Recent Development
    Table 108. Hulan Bio Company Details
    Table 109. Hulan Bio Business Overview
    Table 110. Hulan Bio Vaccine Product
    Table 111. Hulan Bio Revenue in Vaccine Business (2016-2021) & (US$ Million)
    Table 112. Hulan Bio Recent Development
    Table 113. Indian Immunologicals Company Details
    Table 114. Indian Immunologicals Business Overview
    Table 115. Indian Immunologicals Vaccine Product
    Table 116. Indian Immunologicals Revenue in Vaccine Business (2016-2021) & (US$ Million)
    Table 117. Indian Immunologicals Recent Development
    Table 118. Merck Company Details
    Table 119. Merck Business Overview
    Table 120. Merck Vaccine Product
    Table 121. Merck Revenue in Vaccine Business (2016-2021) & (US$ Million)
    Table 122. Merck Recent Development
    Table 123. Minhai Biotechnology Company Details
    Table 124. Minhai Biotechnology Business Overview
    Table 125. Minhai Biotechnology Vaccine Product
    Table 126. Minhai Biotechnology Revenue in Vaccine Business (2016-2021) & (US$ Million)
    Table 127. Minhai Biotechnology Recent Development
    Table 128. Mitsubishi Tanabe Pharma Company Details
    Table 129. Mitsubishi Tanabe Pharma Business Overview
    Table 130. Mitsubishi Tanabe Pharma Vaccine Product
    Table 131. Mitsubishi Tanabe Pharma Revenue in Vaccine Business (2016-2021) & (US$ Million)
    Table 132. Mitsubishi Tanabe Pharma Recent Development
    Table 133. Moderna Therapeutics Company Details
    Table 134. Moderna Therapeutics Business Overview
    Table 135. Moderna Therapeutics Vaccine Product
    Table 136. Moderna Therapeutics Revenue in Vaccine Business (2016-2021) & (US$ Million)
    Table 137. Moderna Therapeutics Recent Development
    Table 138. Mylan Company Details
    Table 139. Mylan Business Overview
    Table 140. Mylan Vaccine Product
    Table 141. Mylan Revenue in Vaccine Business (2016-2021) & (US$ Million)
    Table 142. Mylan Recent Development
    Table 143. Plumbline Life Sciences Company Details
    Table 144. Plumbline Life Sciences Business Overview
    Table 145. Plumbline Life Sciences Vaccine Product
    Table 146. Plumbline Life Sciences Revenue in Vaccine Business (2016-2021) & (US$ Million)
    Table 147. Plumbline Life Sciences Recent Development
    Table 148. Sanofi Company Details
    Table 149. Sanofi Business Overview
    Table 150. Sanofi Vaccine Product
    Table 151. Sanofi Revenue in Vaccine Business (2016-2021) & (US$ Million)
    Table 152. Sanofi Recent Development
    Table 153. Translate Bio Company Details
    Table 154. Translate Bio Business Overview
    Table 155. Translate Bio Vaccine Product
    Table 156. Translate Bio Revenue in Vaccine Business (2016-2021) & (US$ Million)
    Table 157. Translate Bio Recent Development
    Table 158. Walvax Biotechnology Company Details
    Table 159. Walvax Biotechnology Business Overview
    Table 160. Walvax Biotechnology Vaccine Product
    Table 161. Walvax Biotechnology Revenue in Vaccine Business (2016-2021) & (US$ Million)
    Table 162. Walvax Biotechnology Recent Development
    Table 163. Wuhan Institute of Biological Products Company Details
    Table 164. Wuhan Institute of Biological Products Business Overview
    Table 165. Wuhan Institute of Biological Products Vaccine Product
    Table 166. Wuhan Institute of Biological Products Revenue in Vaccine Business (2016-2021) & (US$ Million)
    Table 167. Wuhan Institute of Biological Products Recent Development
    Table 168. Zoties Company Details
    Table 169. Zoties Business Overview
    Table 170. Zoties Vaccine Product
    Table 171. Zoties Revenue in Vaccine Business (2016-2021) & (US$ Million)
    Table 172. Zoties Recent Development
    Table 173. Research Programs/Design for This Report
    Table 174. Key Data Information from Secondary Sources
    Table 175. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Vaccine Market Share by Type: 2020 VS 2027
    Figure 2. Varicella Vaccine Features
    Figure 3. Influenza Vaccine Features
    Figure 4. Polio Vaccine Features
    Figure 5. Hepatitis A Vaccine Features
    Figure 6. Rabies Vaccine Features
    Figure 7. BCG Vaccine Features
    Figure 8. Hepatitis B Features
    Figure 9. Pertussis, Diphtheria, Tetanus Features
    Figure 10. Pneumococcal Features
    Figure 11. Others Features
    Figure 12. Global Vaccine Market Share by Application: 2020 VS 2027
    Figure 13. For Adult Case Studies
    Figure 14. For Child Case Studies
    Figure 15. Vaccine Report Years Considered
    Figure 16. Global Vaccine Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 17. Global Vaccine Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 18. Global Vaccine Market Share by Regions: 2020 VS 2027
    Figure 19. Global Vaccine Market Share by Regions (2022-2027)
    Figure 20. Global Vaccine Market Share by Players in 2020
    Figure 21. Global Top Vaccine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccine as of 2020
    Figure 22. The Top 10 and 5 Players Market Share by Vaccine Revenue in 2020
    Figure 23. Global Vaccine Revenue Market Share by Type (2016-2021)
    Figure 24. Global Vaccine Revenue Market Share by Type (2022-2027)
    Figure 25. North America Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. North America Vaccine Market Share by Type (2016-2027)
    Figure 27. North America Vaccine Market Share by Application (2016-2027)
    Figure 28. North America Vaccine Market Share by Country (2016-2027)
    Figure 29. United States Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Canada Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Europe Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Europe Vaccine Market Share by Type (2016-2027)
    Figure 33. Europe Vaccine Market Share by Application (2016-2027)
    Figure 34. Europe Vaccine Market Share by Country (2016-2027)
    Figure 35. Germany Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. France Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. U.K. Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Italy Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Russia Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Nordic Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Asia-Pacific Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Asia-Pacific Vaccine Market Share by Type (2016-2027)
    Figure 43. Asia-Pacific Vaccine Market Share by Application (2016-2027)
    Figure 44. Asia-Pacific Vaccine Market Share by Region (2016-2027)
    Figure 45. China Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Japan Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. South Korea Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Southeast Asia Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. India Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Australia Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Latin America Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Latin America Vaccine Market Share by Type (2016-2027)
    Figure 53. Latin America Vaccine Market Share by Application (2016-2027)
    Figure 54. Latin America Vaccine Market Share by Country (2016-2027)
    Figure 55. Mexico Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Brazil Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Middle East & Africa Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Middle East & Africa Vaccine Market Share by Type (2016-2027)
    Figure 59. Middle East & Africa Vaccine Market Share by Application (2016-2027)
    Figure 60. Middle East & Africa Vaccine Market Share by Country (2016-2027)
    Figure 61. Turkey Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 62. Saudi Arabia Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 63. UAE Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 64. AstraZeneca Revenue Growth Rate in Vaccine Business (2016-2021)
    Figure 65. BioNTech Revenue Growth Rate in Vaccine Business (2016-2021)
    Figure 66. Boehringer-Ingelheim Revenue Growth Rate in Vaccine Business (2016-2021)
    Figure 67. CCBIO Revenue Growth Rate in Vaccine Business (2016-2021)
    Figure 68. CSL Revenue Growth Rate in Vaccine Business (2016-2021)
    Figure 69. CureVac Revenue Growth Rate in Vaccine Business (2016-2021)
    Figure 70. Elanco Revenue Growth Rate in Vaccine Business (2016-2021)
    Figure 71. GSK Revenue Growth Rate in Vaccine Business (2016-2021)
    Figure 72. Hulan Bio Revenue Growth Rate in Vaccine Business (2016-2021)
    Figure 73. Indian Immunologicals Revenue Growth Rate in Vaccine Business (2016-2021)
    Figure 74. Merck Revenue Growth Rate in Vaccine Business (2016-2021)
    Figure 75. Minhai Biotechnology Revenue Growth Rate in Vaccine Business (2016-2021)
    Figure 76. Mitsubishi Tanabe Pharma Revenue Growth Rate in Vaccine Business (2016-2021)
    Figure 77. Moderna Therapeutics Revenue Growth Rate in Vaccine Business (2016-2021)
    Figure 78. Mylan Revenue Growth Rate in Vaccine Business (2016-2021)
    Figure 79. Plumbline Life Sciences Revenue Growth Rate in Vaccine Business (2016-2021)
    Figure 80. Sanofi Revenue Growth Rate in Vaccine Business (2016-2021)
    Figure 81. Translate Bio Revenue Growth Rate in Vaccine Business (2016-2021)
    Figure 82. Walvax Biotechnology Revenue Growth Rate in Vaccine Business (2016-2021)
    Figure 83. Wuhan Institute of Biological Products Revenue Growth Rate in Vaccine Business (2016-2021)
    Figure 84. Zoties Revenue Growth Rate in Vaccine Business (2016-2021)
    Figure 85. Bottom-up and Top-down Approaches for This Report
    Figure 86. Data Triangulation
    Figure 87. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AstraZeneca
BioNTech
Boehringer-Ingelheim
CCBIO
CSL
CureVac
Elanco
GSK
Hulan Bio
Indian Immunologicals
Merck
Minhai Biotechnology
Mitsubishi Tanabe Pharma
Moderna Therapeutics
Mylan
Plumbline Life Sciences
Sanofi
Translate Bio
Walvax Biotechnology
Wuhan Institute of Biological Products
Zoties
Frequently Asked Questions
Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports